Tumor PD-L1 binds to PD-1 receptors on infiltrating effector T-cells, inhibiting their cytotoxic activity and thereby rendering malignant cells resistant to CTL-mediated destruction [37]. This evidence concerns the gene CD274 and neoplasm.